Randomized Controlled Trial
A randomized trial to evaluate the relative protection against post-percutaneous coronary intervention microvascular dysfunction, ischemia, and inflammation among antiplatelet and antithrombotic agents: the PROTECT-TIMI-30...
J. Am. Coll. Cardiol. 2006 Jun 20;47(12):2364-73.
Review
Clopidogrel and ticlopidine: P2Y12 adenosine diphosphate-receptor antagonists for the prevention of atherothrombosis.
Semin. Thromb. Hemost. 2005 Apr 1;31(2):174-83.
Randomized Controlled Trial
The efficacy and safety of prasugrel with and without a glycoprotein IIb/IIIa inhibitor in patients with acute coronary syndromes undergoing percutaneous intervention: a TRITON-TIMI 38 (Trial to Assess Improvement in Therapeutic...
J. Am. Coll. Cardiol. 2009 Aug 18;54(8):678-85.